Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Seoane

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Nature Materials|November 3, 2014
Metal-organic framework nanosheets in polymer composite materials for gas separationTania Rodenas, Ignacio Luz, Gonzalo Prieto, et al.
Respiratory Research|September 10, 2020
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studiesVictor Balaguer, Muna Albayaty, Eulalia Jimenez, et al.
Respiratory Research|September 10, 2020
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilatorEulalia Jimenez, Carol Astbury, Muna Albayaty, et al.
NPJ Primary Care Respiratory Medicine|May 1, 2015
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studySergi Pascual, Jan Feimer, Anthony De Soyza, et al.
Chemical Science|July 5, 2021
Visualizing defects and pore connectivity within metal-organic frameworks by X-ray transmission tomographyRafael Mayorga-González, Miguel Rivera-Torrente, Nikolaos Nikolopoulos, et al.
The European Respiratory Journal|August 6, 2016
Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD studyClaus Vogelmeier, Pier Luigi Paggiaro, Jordi Dorca, et al.
Expert Opinion on Drug Delivery|June 11, 2013
Preference, satisfaction and errors with two dry powder inhalers in patients with COPDJob van der Palen, Thomas Ginko, Axel Kroker, et al.
Angewandte Chemie (International Ed. in English)|February 22, 2018
Revealing the Transient Concentration of CO<sub>2</sub> in a Mixed-Matrix Membrane by IR Microimaging and Molecular ModelingSeungtaik Hwang, Rocio Semino, Beatriz Seoane, et al.
American Journal of Respiratory and Critical Care Medicine|April 6, 2019
The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group StudyJaclyn A Smith, Lorcan McGarvey, Alyn H Morice, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 10, 2018
Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD StudyRobert A Wise, Kenneth R Chapman, Benjamin M Scirica, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Nature Materials|November 3, 2014
Metal-organic framework nanosheets in polymer composite materials for gas separationTania Rodenas, Ignacio Luz, Gonzalo Prieto, et al.
Respiratory Research|September 10, 2020
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studiesVictor Balaguer, Muna Albayaty, Eulalia Jimenez, et al.
Respiratory Research|September 10, 2020
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilatorEulalia Jimenez, Carol Astbury, Muna Albayaty, et al.
NPJ Primary Care Respiratory Medicine|May 1, 2015
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studySergi Pascual, Jan Feimer, Anthony De Soyza, et al.
Chemical Science|July 5, 2021
Visualizing defects and pore connectivity within metal-organic frameworks by X-ray transmission tomographyRafael Mayorga-González, Miguel Rivera-Torrente, Nikolaos Nikolopoulos, et al.
The European Respiratory Journal|August 6, 2016
Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD studyClaus Vogelmeier, Pier Luigi Paggiaro, Jordi Dorca, et al.
Expert Opinion on Drug Delivery|June 11, 2013
Preference, satisfaction and errors with two dry powder inhalers in patients with COPDJob van der Palen, Thomas Ginko, Axel Kroker, et al.
Angewandte Chemie (International Ed. in English)|February 22, 2018
Revealing the Transient Concentration of CO<sub>2</sub> in a Mixed-Matrix Membrane by IR Microimaging and Molecular ModelingSeungtaik Hwang, Rocio Semino, Beatriz Seoane, et al.
American Journal of Respiratory and Critical Care Medicine|April 6, 2019
The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group StudyJaclyn A Smith, Lorcan McGarvey, Alyn H Morice, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 10, 2018
Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD StudyRobert A Wise, Kenneth R Chapman, Benjamin M Scirica, et al.
Pageof 6